The influence of high-density lipoprotein (HDL) and HDL subfractions on insulin secretion and cholesterol efflux in pancreatic derived β-cells. 2021

A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
Unit of Molecular Biology and Genomic Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga #15, Tlalpan, Belisario Domínguez Sección XVI, P.C. 14080, Mexico City, Mexico.

BACKGROUND High-density lipoprotein (HDL) is considered a complex plasma-circulating particle with subfractions that vary in function, size, and chemical composition. We sought to test the effects of HDL, and HDL subfractions on insulin secretion and cholesterol efflux in the β-cell line MIN-6. METHODS We used total HDL and HDL subfractions 2a, 2b, 3a, 3b, and 3c, isolated from human plasma, to test insulin secretion under different glucose concentrations as well as insulin content and cholesterol efflux in the insulinoma MIN-6 cell line. RESULTS Incubation of MIN-6 cells with low glucose and total HDL increased insulin release two-fold. Meanwhile, when high glucose and HDL were used, insulin release increased more than five times. HDL subfractions 2a, 2b, 3a, 3b, and 3c elicited higher insulin secretion and cholesterol efflux than their respective controls, at both low and high glucose concentrations. The insulin content of the MIN-6 cells incubated with low glucose and any of the five HDL subclasses had a modest reduction compared with their controls. However, there were no statistically significant differences between each HDL subfraction on their capacity of eliciting insulin secretion, insulin content, or cholesterol efflux. CONCLUSIONS HDL can trigger insulin secretion under low, normal, and high glucose conditions. We found that all HDL subfractions exhibit very similar capacity to increase insulin secretion and cholesterol efflux. This is the first report demonstrating that HDL subfractions act both as insulin secretagogues (under low glucose) and insulin secretion enhancers (under high glucose) in the MIN-6 cell line.

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
February 1988, Atherosclerosis,
A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
May 2020, Arteriosclerosis, thrombosis, and vascular biology,
A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
October 2018, Lipids,
A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
August 1981, The Journal of biological chemistry,
A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
April 2006, The Journal of biological chemistry,
A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
May 1994, Journal of gerontology,
A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
February 1987, Pediatrics,
A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
January 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation,
A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
December 1991, Journal of lipid research,
A Ochoa-Guzmán, and D Guillén-Quintero, and L Muñoz-Hernández, and A García, and E Díaz-Díaz, and O Pérez-Méndez, and R Rodríguez-Guillén, and I B Mitre-Aguilar, and A Zentella-Dehesa, and C A Aguilar-Salinas, and M T Tusié-Luna
August 2016, Archives of medical science : AMS,
Copied contents to your clipboard!